Clinical trial
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
NCT06069024 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 15, 2021
- Completion date
- May 31, 2023
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.